Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis

Clinical Chemistry

Volumn 51, Issue 1, 2005, Pages 261-263

  Hoffman, Ilse E A ^a   Peene, Isabelle ^a   Pottel, Hans ^b   Union, Ann ^b   Hulstaert, Frank ^b   Meheus, Lydie ^b   Lebeer, Katleen ^b   De Clercq, Luc ^c   Schatteman, Lieve ^c   Poriau, Stefaan ^d   Mielants, Herman ^a,c   Veys, Eric M ^a   De Keyser, Filip ^a,d  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b INNOGENETICS   (Belgium)

^c SINT AUGUSTINUS HOSPITAL   (Belgium)

^d Elisabeth Hospital   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FILAGGRIN; HLA ANTIGEN; PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADULT; AGED; ANTIBODY DETECTION; AREA UNDER THE CURVE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; LABORATORY TEST; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; MULTICENTER STUDY; PREDICTION; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SINGLE BLIND PROCEDURE; SYMPTOM; TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CITRULLINE; EPITOPES; FOLLOW-UP STUDIES; HLA ANTIGENS; HUMANS; MIDDLE AGED; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RHEUMATOID FACTOR;

EID: 19944366229     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.034728     Document Type: Article

References (22)

1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
2. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C; Smolen JS, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000;2:236-43.
3. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 2001; 47:1089-93.
4. Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, Guerne PA. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology (Oxford) 2002;41:809-14.
5. Bas S, Genevay S, Meyer O, Gabay C. Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology (Oxford) 2003;42:677-80.
6. Union A, Meheus L, Humbel RL, Conrad K, Steiner G, Moereels H, et al. Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay. Arthritis Rheum 2002;46:1185-95.
7. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43:155-63.
8. Vincent C, Nogueira L, Sebbag M, Chapuy-Regaud S, Arnaud M, Letourneur O, et al. Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay; a highly effective test for the diagnosis of rheumatoid arthritis. Arthritis Rheum 2002;46:2051-8.
9. Nogueira L, Chapuy-Regaud S, Constantin A, Clavel C, Sebbag M, Cantagrel A, et al. Autoantibodies to deiminated fibrinogen are the most efficient serological criterion for early rheumatoid arthritis diagnosis [Abstract]. Arthritis Res Ther 2003;5:S6.
10. Peene I, De Rycke L, Baeten D, Hoffman IEA, Veys EM, De Keyser F. History and diagnostic value of antibodies to citrullinated proteins in rheumatoid arthritis [Review]. Int J Immunopathol Pharmacal 2004;17:107-16.
11. De Rycke L, Peene I, Hoffman IEA, Kruithof E, Union A, Meheus L, et al. Rheumatoid factor and anti-citrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis, in press.
12. Castelar Pinheiro G. Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis. Ann Intern Med 2003;139:234-5.
13. Dubucquol S, Solau-Servais E, Lefranc D, Marguerie L, Sibilia J, Goetz J, et al. Evaluation of anti-citrullinated fillagrin antibodies as hallmarks for the diagnosis of rheumatoid arthritis. Ann Rheum Dis 2004;63:415-9.
14. Suzuki K, Sawada T, Murakamani A, Matsui T, Tohma S, Nakazono K. High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 2003;32:197-204.
15. Lee DM, Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 2003;62:870-4.
16. Winchester R, Dwyer E, Rose S. The genetic basis of rheumatoid arthritis. The shared epitope hypothesis. Rheum Dis Clin North Am 1992;18:761-83.
17. de Vries N, van Elderen C, Tijssen H, van Riel PL, van de Putte LB. No support for HLA-DQ encoded susceptibility in rheumatoid arthritis. Arthritis Rheum. 1999;42:1621-7.
18. Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T, et al. HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias. Arthritis Rheum 2002;46:2320-9.
19. Harper R, Reeves B. Reporting of precision of estimates for diagnostic accuracy; a review [Review]. BMJ 1999;318:1322-33.
20. Saraux A, Berthelot JM, Chales G, Le Henaff C, Mary JY, Thorel JB, et al. Value of laboratory tests in early prediction of rheumatoid arthritis. Arthritis Rheum 2002;47:155-65.
21. Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA. Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 2002;29:2074-6.
22. Milicic A, Lee D, Brown MA, Darke C, Wordsworth BP. HLA-DR/DQ haplotype in rheumatoid arthritis: novel allelic associations in UK Caucasians. J Rheumatol 2002;29:1821-6.